BSE filing, NSE: SYNCOMF. Summary written from the filing by ALFA Finder's alert engine.
Syncom Formulation (India) Ltd: key numbers
- Share price
- ₹20.38
- Market cap
- ₹1,916 Cr
- Revenue (annual)
- ₹489.2 Cr
- Net profit (annual)
- ₹76.44 Cr
- P/E (TTM)
- 22.4×Sector 46.5×
- Promoter holding
- 50.57%+0.00% QoQ
- FII holding
- 2.23%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Syncom Formulation (India) Ltd
All →Syncom Formulation (India) Dividend
Syncom Formulations (India) Ltd shareholders approved a final dividend of Rs. 0.10 per equity share at the 38th AGM, totaling Rs. 9.40 Crore.
- Value
- ₹9.40 Cr
Syncom Formulation (India) Management Change
Syncom Formulations (India) Limited announced the appointments of Rahul Vijay Bankda as Managing Director and Rinki Ankit Bankda as Whole Time Director. Ruchi Jindal was reappointed.
Syncom Formulation (India) Annual General Meeting
Syncom Formulations (India) Limited held its 38th Annual General Meeting on September 30, 2026, via video conferencing to transact various ordinary and special business items.
Syncom Formulation (India) Other Announcement
Syncom Formulations' promoters have voluntarily waived their right to the proposed final dividend of ₹0.10 per share. This waiver reduces total dividend payout obligations.
- Value
- ₹4.75 Cr
Syncom Formulation (India) Other Announcement
Syncom Formulations fixed 23 Sep 2026 as record date for a proposed 10% dividend (Rs.0.10/share) pending AGM approval. The 38th AGM is scheduled for 30 Sep 2026.
Syncom Formulation (India) Other Announcement
Syncom Formulations (India) Limited informed exchanges about the dispatch of letters to shareholders with unregistered email addresses, providing instructions to access the 38th AGM Notice and Annual Report.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.